Generation Development Group posts record December quarter earnings and inflows

Generation Development Group lifted FUM 36% in the December quarter.

| More on:
A share market investment manager monitors share price movements on his mobile phone and laptop

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Generation Development Group Ltd (ASX: GDG) share price is in focus after the company posted a record December quarter, with total group Funds Under Management (FUM) jumping 36% year-on-year to $34.5 billion and Generation Life gross sales inflows surging 57% to $393 million.

What did Generation Development Group report?

  • Group Funds Under Management (FUM) rose to $34.5 billion, up 36% on the prior corresponding period (PCP).
  • Generation Life delivered record quarterly gross sales inflows of $393 million, up 57% PCP, and FUM up 34% to $5.2 billion.
  • Evidentia achieved net inflows of $1.6 billion for the quarter and maintained a 100% tailored client retention rate.
  • Lonsec saw continued iRate subscription growth and completed the Pound for Pound benchmarking pilot in the UK.
  • Key strategic wins included finalising a long-term alliance with Ironbark Asset Management and acquiring Encore Advisory Group.

What else do investors need to know?

During the quarter, Generation Development Group maintained strong momentum across all divisions. Evidentia expanded its client base, launched several new managed account solutions, and completed the Encore Advisory Group acquisition to strengthen its practice management offering.

Generation Life posted record adviser engagement, with adviser event attendance up 49%, and extended its market leadership in investment bonds. Meanwhile, the Lonsec business focused on innovation, with new governance tools ready for market in Q3, and ongoing integration efforts targeting adviser workflow solutions.

What did Generation Development Group management say?

Felipe Araujo, Chief Executive Officer, Generation Life said:

We continue to see strong and consistent momentum in our inflows, underpinned by deep adviser engagement and growing awareness of the role investment bonds play in long-term wealth planning. We are investing now in capability, partnerships and product development to ensure Generation Life is well positioned to support advisers and clients as future growth opportunities continue to emerge.

What's next for Generation Development Group?

Looking ahead, Generation Development Group is prioritising investment in technology, innovation, and new product development to capture further growth. The recent Ironbark alliance and Encore Advisory acquisition are set to drive significant inflows and enhance the group's advisory and investment capabilities.

Management remains confident about second-half inflows, with several contracted schemes scheduled to commence in Q3. The group will continue to focus on efficiency, strategic partnerships, and expanding its adviser and client base through FY26 and beyond.

Generation Development Group share price snapshot

Over the past 12 months, Generation Development Group share have risen 41%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 4% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Generation Development Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Share Market News

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Three small children reach up to hold a toy rocket high above their heads in a green field with a blue sky above them.
Growth Shares

These 4 ASX 200 stocks could jump another 70% to 80% in 2026

These stocks are expected to rocket higher.

Read more »

Two excited woman pointing out a bargain opportunity on a laptop.
Share Gainers

3 ASX 200 stocks jumping higher in this week's falling market

Investors shrugged off the broader market retrace and piled into these three ASX 200 stocks this week.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why EOS, Lotus Resources, REA, and Web Travel shares are dropping today

These shares are ending the week deep in the red. But why?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Brambles, HMC Capital, ResMed, and Rio Tinto shares are rising today

These shares are avoiding the selloff and are pushing higher on Friday.

Read more »

A woman looks shocked as she drinks a coffee while reading the paper.
Share Fallers

Why is the Web Travel share price crashing 41% on Friday?

ASX investors are pummelling Web Travel shares today. But why?

Read more »

A man looking at his laptop and thinking.
Materials Shares

Rio Tinto shares charge higher after Glencore merger collapses

The parties couldn't come to an agreement.

Read more »

a group of doctors and medical staff in uniform high five in celebration in a hospital setting
Share Market News

Neuren Pharmaceuticals kicks off Phase 3 trial in rare syndrome

Neuren Pharmaceuticals shares are on watch after dosing began in its key Phase 3 trial for Phelan-McDermid syndrome.

Read more »